VIENNA — DirectSens, a pioneer in next-generation biosensor technology, has announced the acquisition of its LactoSens technology by Kerry Group, a global leader in taste and nutrition.
The acquisition of LactoSens reflects DirectSens’ success in developing end-to-end biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers.
“We’re excited to bring LactoSens into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry," said Ronan Moloney, vice president, enzymes at Kerry Group.
Since its introduction, eight years ago, LactoSens has become the industry’s preferred solution for fast, accurate and cost-effective lactose detection. It is widely used in food and beverage manufacturing, enabling producers to meet stringent regulatory requirements while running their processes efficiently. Its real-time analysis capabilities give manufacturers a competitive edge, solidifying LactoSens as a market leader.
For DirectSens, this acquisition proves the market value of its biosensor technology.
“This deal underscores the quality of our biosensor technology and manufacturing capabilities. We will continue to execute on our vision to develop and deliver fast and precise biosensor solutions for key analytes to the global marketplace.” said CEO Dr. Christoph Sygmund.
